{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:13:31Z","timestamp":1777439611650,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005009","name":"Stiftelsen Assar Gabrielssons Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jim.2019.112681","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T11:18:55Z","timestamp":1571311135000},"page":"112681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Expression of tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) in minor salivary glands and saliva"],"prefix":"10.1016","volume":"476","author":[{"given":"H\u00fclya","family":"\u00c7evik-Aras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Kjeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2019.112681_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2015.09.001","article-title":"Therapeutic applications of TRAIL receptor agonists in cancer and beyond","volume":"155","author":"Amarante-Mendes","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jim.2019.112681_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.0022-202x.2001.01380.x","article-title":"Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation","volume":"117","author":"Bachmann","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"25","key":"10.1016\/j.jim.2019.112681_bb0015","doi-asserted-by":"crossref","first-page":"22522","DOI":"10.1074\/jbc.M010505200","article-title":"The cytokines tumor necrosis factor-alpha (TNF-alpha ) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein","volume":"276","author":"Basile","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jim.2019.112681_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.prp.2009.09.005","article-title":"Differential expression of the TRAIL\/TRAIL-receptor system in patients with inflammatory bowel disease","volume":"206","author":"Brost","year":"2010","journal-title":"Pathol. Res. Pract."},{"issue":"11","key":"10.1016\/j.jim.2019.112681_bb0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1440-1681.2009.05258.x","article-title":"Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses","volume":"36","author":"Collison","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.jim.2019.112681_bb0035","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4049\/jimmunol.168.3.1356","article-title":"Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice","volume":"168","author":"Cretney","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2019.112681_bb0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jim.2014.04.013","article-title":"Quantitative detection of epidermal growth factor and interleukin-8 in whole saliva of healthy individuals","volume":"408","author":"Dafar","year":"2014","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.jim.2019.112681_bb0045","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/odi.12654","article-title":"Salivary levels of interleukin-8 and growth factors are modulated in patients with geographic tongue","volume":"23","author":"Dafar","year":"2017","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.jim.2019.112681_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2353\/ajpath.2007.060068","article-title":"FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major","volume":"170","author":"Eidsmo","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.jim.2019.112681_bb0055","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jlb.61.5.567","article-title":"Wherefore interferon?","volume":"61","author":"Gresser","year":"1997","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.jim.2019.112681_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1067\/mpr.2001.113778","article-title":"A review of saliva: normal composition, flow, and function","volume":"85","author":"Humphrey","year":"2001","journal-title":"J. Prosthet. Dent."},{"key":"10.1016\/j.jim.2019.112681_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00016489309126195","article-title":"Kinetics of epidermal growth factor in saliva","volume":"500","author":"Ino","year":"1993","journal-title":"Acta Otolaryngol. Suppl."},{"issue":"6","key":"10.1016\/j.jim.2019.112681_bb0070","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1046\/j.1523-1747.2003.12636.x","article-title":"Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes","volume":"121","author":"Jansen","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.jim.2019.112681_bb0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.oraloncology.2011.02.006","article-title":"The role of salivary cytokine biomarkers in tongue cancer invasion and mortality","volume":"47","author":"Korostoff","year":"2011","journal-title":"Oral Oncol."},{"issue":"44","key":"10.1016\/j.jim.2019.112681_bb0080","doi-asserted-by":"crossref","first-page":"29247","DOI":"10.1074\/jbc.273.44.29247","article-title":"Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand","volume":"273","author":"Kothny-Wilkes","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jim.2019.112681_bb0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1074\/jbc.M107795200","article-title":"Molecular cross-talk between the TRAIL and interferon signaling pathways","volume":"277","author":"Kumar-Sinha","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jim.2019.112681_bb0090","first-page":"791","article-title":"Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sj\u00f6gren's syndrome","volume":"20","author":"Matsumura","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5996","key":"10.1016\/j.jim.2019.112681_bb0095","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/312724a0","article-title":"Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin","volume":"312","author":"Pennica","year":"1984","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.jim.2019.112681_bb0100","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","article-title":"Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family","volume":"271","author":"Pitti","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.jim.2019.112681_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050639","article-title":"TRAIL and FasL functions in cancer and autoimmune diseases: towards an increasing complexity","volume":"11","author":"Rossin","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.jim.2019.112681_bb0110","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B","article-title":"Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha\/beta","volume":"31","author":"Sato","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.jim.2019.112681_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jcp.21589","article-title":"Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye","volume":"218","author":"Secchiero","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.jim.2019.112681_bb0120","first-page":"87","article-title":"The biology of TRAIL and the role of TRAIL-based therapeutics in infectious diseases","volume":"8","author":"Shepard","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"8","key":"10.1016\/j.jim.2019.112681_bb0125","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.4049\/jimmunol.154.8.3806","article-title":"Expression of the Fas ligand in cells of T cell lineage","volume":"154","author":"Suda","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2019.112681_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2407-7-108","article-title":"Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression","volume":"7","author":"Vigneswaran","year":"2007","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.jim.2019.112681_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2407-7-108","article-title":"Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression","volume":"25","author":"Vigneswaran","year":"2007","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.jim.2019.112681_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.jim.2019.112681_bb0145","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jim.2019.112681_bb0150","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.175.9.5586","article-title":"Cutting edge: TRAIL deficiency accelerates hematological malignancies","volume":"175","author":"Zerafa","year":"2005","journal-title":"J. Immunol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175919302145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175919302145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:35:45Z","timestamp":1758299745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175919302145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":29,"alternative-id":["S0022175919302145"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2019.112681","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) in minor salivary glands and saliva","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2019.112681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112681"}}